Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
about
ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngiomaAmeloblastoma: A Review of Recent Molecular Pathogenetic DiscoveriesAmeloblastoma Phenotypes Reflected in Distinct Transcriptome Profiles.Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanomaMolecular Signaling in Benign Odontogenic Neoplasia PathogenesisBRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.Immunohistochemical biomarkers in ameloblastomas.Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature.The regulation of bone turnover in ameloblastoma using an organotypic in vitro co-culture model.Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.Treatment of ameloblastoma and ameloblastic carcinoma with radiotherapy.Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors.BRAF V600E and loss of heterozygosity assessment in benign oralneural tumours.Orbital invasion of ameloblastoma: A systematic review apropos of a rare entity.Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation
P2860
Q26777288-2D163075-191A-4EF4-9C5A-77BE464C02D4Q26781648-420E7B0D-44A1-44A0-B1DD-BD23E344FC54Q36095206-8FAB2241-8F40-445D-A629-7D9B9D0B0003Q37157712-7CAAA168-B0CD-460D-A8F0-2AFB1DB39F0BQ37183900-3526BE09-1F3B-4CCE-92C3-858F0DF4C2D5Q38569221-5BBD6DDE-707E-40FA-A6CB-B371AA619B76Q38939867-3F598775-A617-474D-B55E-61A7E1841B87Q39103785-440B45E0-F9FE-4C72-96AF-CBC0E67E6410Q41268590-6CF2A97F-CB62-408C-8FF1-20D6AA5C5261Q46090273-38BBA2B5-E1F6-4068-AE44-4C98C9DAC562Q47908389-72BDD698-3FC9-4E42-9A4E-5CC88CFD25C0Q50317399-11BA0FE6-D045-4D8B-8DEB-25E793BDE78EQ53467985-31D13C4C-AE29-4CF3-AFDA-18BF5DC895F5Q54936002-8E0EAC89-9564-4EB4-9DFF-4C582EA7EC48Q58748443-5968EEF3-67A9-46FF-B83C-13202F39B010
P2860
Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Clinical and radiographic resp ...... rapy in stage 4 ameloblastoma.
@en
Clinical and radiographic resp ...... rapy in stage 4 ameloblastoma.
@nl
type
label
Clinical and radiographic resp ...... rapy in stage 4 ameloblastoma.
@en
Clinical and radiographic resp ...... rapy in stage 4 ameloblastoma.
@nl
prefLabel
Clinical and radiographic resp ...... rapy in stage 4 ameloblastoma.
@en
Clinical and radiographic resp ...... rapy in stage 4 ameloblastoma.
@nl
P2093
P2860
P356
P1476
Clinical and radiographic resp ...... rapy in stage 4 ameloblastoma.
@en
P2093
Alison M Ivey
Frederic J Kaye
Robert W Allan
Walter E Drane
William M Mendenhall
P2860
P356
10.1093/JNCI/DJU378
P407
P577
2014-12-03T00:00:00Z